Plant-Derived Vaccines Versus COVID-19
Despite success with the COVID-19 vaccine roll-out, ever-increasing demand across the world continues to put pressure on vaccine manufacturing and supply chains. Recent developments in plant-derived vaccines, however, offer a potential solution. GSK is one company currently implementing phase III...
4 years agoPlant-Derived Vaccines Versus COVID-19
Despite success with the COVID-19 vaccine roll-out, ever-increasing demand across the world continues to put pressure on vaccine manufacturing and supply chains. Recent developments in plant-derived vaccines, however, offer a potential solution. GSK is one company currently implementing phase III...
4 years agoInnovations in Oncology: An Interview with Raluca Budiu-Predoiu
“These are exciting times for all areas of oncology.” With new advances across the oncological board, from immuno-oncology and biomarkers, it is important to keep up with and understand the latest innovations. We spoke to Raluca Budiu-Predoiu, Translational Oncology Principal...
4 years agoInnovations in Oncology: An Interview with Raluca Budiu-Predoiu
“These are exciting times for all areas of oncology.” With new advances across the oncological board, from immuno-oncology and biomarkers, it is important to keep up with and understand the latest innovations. We spoke to Raluca Budiu-Predoiu, Translational Oncology Principal...
4 years agoBroadening the Scope of Therapeutic Treatment – Advancements in Cancer Clinical Trials
With ground-breaking advancements in oncology like check-point inhibitors comes the extensive development of human clinical trials, prioritising patient safety and drug tolerability through pharmacovigilance. Proventa spoke to Chief Medical Officer for Xilio Therapeutics, Martin Huber, for his thoughts regarding exciting...
4 years agoBroadening the Scope of Therapeutic Treatment – Advancements in Cancer Clinical Trials
With ground-breaking advancements in oncology like check-point inhibitors comes the extensive development of human clinical trials, prioritising patient safety and drug tolerability through pharmacovigilance. Proventa spoke to Chief Medical Officer for Xilio Therapeutics, Martin Huber, for his thoughts regarding exciting...
4 years agoWeekly News Round-up – 12/3/21
In the news this week,real-world data has found the Pfizer vaccine to have high effectiveness against asymptomatic COVID-19. In other news, the EMA has advised continued use of AstraZeneca’s vaccine despite blood clot scares, and Zolgensma is set to be...
4 years agoWeekly News Round-up – 12/3/21
In the news this week,real-world data has found the Pfizer vaccine to have high effectiveness against asymptomatic COVID-19. In other news, the EMA has advised continued use of AstraZeneca’s vaccine despite blood clot scares, and Zolgensma is set to be...
4 years agoWeekly News Round-up – 5/3/21
In the news this week, Merck & J&J team up to boost COVID vaccine supply, while Novavax hopes to have its vaccine approved in May. In other news, Pfizer’s COVID vaccine may less effective in obese individuals, and Merck buys...
4 years agoWeekly News Round-up – 5/3/21
In the news this week, Merck & J&J team up to boost COVID vaccine supply, while Novavax hopes to have its vaccine approved in May. In other news, Pfizer’s COVID vaccine may less effective in obese individuals, and Merck buys...
4 years agoData Capture, Integration and Storage in Decentralised Trials
Decentralisation of virtual trials has grown rapidly during the COVID-19 pandemic, changing the nature of clinical trials for a number of large and small pharma companies. While this new way of conducting clinical operations promises to reduce costs and increase...
4 years agoData Capture, Integration and Storage in Decentralised Trials
Decentralisation of virtual trials has grown rapidly during the COVID-19 pandemic, changing the nature of clinical trials for a number of large and small pharma companies. While this new way of conducting clinical operations promises to reduce costs and increase...
4 years ago